Business Context and Reporting Period
Company: Globus Medical, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: August 6, 2026
Reporting Period: Three and six months ended June 30, 2026
This filing serves as a notification that the Company issued a press release on August 6, 2026, detailing its sales and operating results for the specified periods. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1) but are not explicitly stated in the body of this Form 8-K.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. It only confirms that results for the three and six months ended June 30, 2026, were reported.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing operating results but does not include specific management commentary, guidance, or outlook within the text provided.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt. The filing notes that the information is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, limiting liability.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 6, 2026) for actual revenue, earnings, and cash flow figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any forward-looking guidance or updated financial projections in the press release.
- Confirm the status of the Company's emerging growth company designation as indicated in the filing.